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ABSTRACT
Background
The asymptomatic phase of HIV infection is characterised by a slow decline of peripheral
blood CD4
þT cells. Why this decline is slow is not understood. One potential explanation is that
the low average rate of homeostatic proliferation or immune activation dictates the pace of a
‘‘runaway’’ decline of memory CD4
þ T cells, in which activation drives infection, higher viral
loads, more recruitment of cells into an activated state, and further infection events. We explore
this hypothesis using mathematical models.
Methods and Findings
Using simple mathematical models of the dynamics of T cell homeostasis and proliferation,
we find that this mechanism fails to explain the time scale of CD4
þmemory T cell loss. Instead it
predicts the rapid attainment of a stable set point, so other mechanisms must be invoked to
explain the slow decline in CD4
þ cells.
Conclusions
A runaway cycle in which elevated CD4
þ T cell activation and proliferation drive HIV
production and vice versa cannot explain the pace of depletion during chronic HIV infection.
We summarize some alternative mechanisms by which the CD4
þmemory T cell homeostatic set
point might slowly diminish. While none are mutually exclusive, the phenomenon of viral
rebound, in which interruption of antiretroviral therapy causes a rapid return to pretreatment
viral load and T cell counts, supports the model of virus adaptation as a major force driving
depletion.
The Editors’ Summary of this article follows the references.
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Untreated HIV infection in humans is characterised by
extensive depletion of CD4
þT cell subsets. In the acute phase,
virus appears to preferentially and efﬁciently target HIV-
speciﬁc [1,2] and effector-memory CD4
þ T cells that reside in
mucosal tissue [3]. Studies of macaques infected with SIV
show the massive loss of memory-phenotype CD4
þcells in the
gut [4], which comprise most of total body CD4
þ cells. Studies
in HIV-infected humans mirror these observations [5–7].
Following this huge systemic insult, the untreated disease
enters a chronic phase in which what remains of the CD4
þ T
cell compartments is slowly eroded over a time scale of
several years. What causes this slow loss is not known.
There is considerable loss of uninfected cells in the chronic
phase [8–12], suggesting that the decline is unlikely to be due
solely to the direct cytopathic effects of the virus [13] or the
removal of infected cells by cytotoxic T lymphocytes (CTLs)
[14]. Chronic immune activation (IA) is frequently cited as an
erosive force [15–18], although it remains more of a strong
association than a detailed mechanism. Elevated levels of
polyclonal CD4
þ T cell activation and proliferation markers
are observed in blood [19–22], and levels of T cell activation
are the strongest predictor of the rate of progression to AIDS
[23].
This increase in IA and immunopathology may be a direct
result of the immune cell interactions with HIV. An
alternative hypothesis is that it is a secondary effect—the
acute mucosal lymphopaenia causes the relocation of
immunogenic gut antigens and systemic responses [24]. In
either case, IA may have diverse effects on both division and
death rates of T cells of all speciﬁcities; altering cytokine
environments and circulation patterns, driving cells into
division and towards senescence through repeated stimula-
tion, or rendering them susceptible to activation-induced cell
death. Further, particularly given the extent of the initial
depletion, some degree of homeostatic compensation will
also contribute to increased average rates of division in CD4
þ
T cell compartments.
Nevertheless, the causal link between the increased CD4
þ
turnover and the slow decline in the blood remains unclear.
The average rates of division and death (turnover) of all CD4
þ
subpopulations are increased, and these rates are fast
compared to the overall rate of T cell depletion. These two
key observations are often restated in terms of a ‘‘tap and
drain’’ analogy [25] in which a small imbalance between the
net rates of replenishment and death drives an inexorable
decline to a state of low CD4
þ T cell numbers. Yet we still
need to explain the mechanism underlying this imbalance, or
the failure of T cell homeostasis.
The increased susceptibility of activated or proliferating T
cells to infection [26] suggests a speciﬁc and plausible
candidate mechanism. Both IA (a response to antigenic
stimulation) and homeostatic proliferation (a response to
lymphopaenia) may fuel the ﬁre by generating new suscep-
tible cells and thus more infection. Elevated turnover results
in more infection, possibly more IA or homeostatic compen-
sation, and runaway depletion of CD4
þ T cells. Speciﬁcally,
can this mechanism provide the slow time scale for decline of
peripheral blood CD4
þmemory T cells? In this paper we use a
simple mathematical model of T cell dynamics to address this
question. We begin by constructing a model of memory CD4
þ
T cell maintenance in health, and discuss how it changes in
the presence of HIV.
Results
Homeostasis of Memory CD4
þ T Cells in Health
The CD4
þ T cell pool comprises naive (antigen-inexper-
ienced) cells and heterogeneous memory (antigen-experi-
enced) populations. The mechanisms by which memory cells
are maintained are not completely deﬁned [27], but survival
and self-renewing proliferation are likely to be controlled by
competition for homeostatic resources such as cytokines and
TCR-self-peptide/MHC interactions, and rates of turnover
may vary between memory subpopulations [28]. In uninfected
individuals, depletion of CD4
þT cells results in compensatory
homeostatic proliferation [29]. This observation has led to the
concept of T cell ‘‘niches,’’ either at the level of the memory
cell compartment as a whole [30], or at the level of individual
clones [31].
With HIV infection in mind, and building on earlier studies
[32,33], we propose a model of healthy memory CD4
þ T cell
homeostasis that distinguishes between resting cells and cells
that have received homeostatic division signals and so are
transiently activated (Figure 1).
We assume that resting memory CD4
þ T cells (x) compete
for homeostatic division signals and receive them at an
average rate a. The mean interdivision time of memory CD4
þ
T cells in healthy humans (1/a) has been estimated using
deuterated glucose labelling and is approximately 15 d for
effector memory CD4
þ T cells, 48 d for central memory cells
[34], or 26 d when averaged over the two compartments [35].
Earlier estimates by other methods suggest it may be as high
as 150 d [36]. We represent competition by assuming that this
time scale decreases (in other words, a increases) under
Figure 1. A Simple Model of Self-Renewing Memory CD4
þ T Cell
Homeostasis in the Absence of HIV Infection, with Density-Dependent
Rates of Division and Death of Resting Cells
dx
dt
¼ 2ry   aðxÞx   dðxÞx
dy
dt
¼ aðxÞx   ry   ly
doi:10.1371/journal.pmed.0040177.g001
PLoS Medicine | www.plosmedicine.org May 2007 | Volume 4 | Issue 5 | e177 0949
CD4
þ T Cell Depletion in HIV Infectionlymphopaenic conditions, as observed experimentally in mice
(unpublished data). We assume that the death rate of resting
memory CD4
þT cells (d) is low [36,37] and density dependent,
falling further under lymphopaenic conditions as survival
signals become more abundant. Our conclusions are weakly
dependent on the density dependence of a(x) and d(x). For the
simulations we show below, we used the linear forms a(x)¼a(1
  x/j) and d(x) ¼ d0 (x/j), where j is a constant that scales the
size of the memory T cell population. With our choice of
parameters, in a ‘‘full’’ memory CD4
þcompartment the mean
time between divisions is 60 d, decreasing to 30 d under
lymphopaenic conditions, and the average lifetime of resting
cells is 400 d.
In our model, cells that have received a homeostatic
division signal enter an actively dividing state (y) and then
return to the resting state at rate r, dividing once as they do so.
The inverse of r is the average time for transit through the cell
cyclefromarestingstate,whichwechoosetobe24h,orr¼1d
 1
[38,39]. Again, our results are not sensitive to this choice. To
maintain homeostasis, our assumption of a low death rate of
resting cells implies that homeostatically dividing cells are
much more susceptible to death, as has been conﬁrmed in
studies of T cell turnover [35]. Using activation markers as an
indicator of progression through the cell cycle, 0.5%–2% of
CD4
þ memory cells are in an activated or dividing state y at
any time in spleen and blood [28,40], which we use to
constrain the death rate of activated cells (l) given a and r.
Our key observation here is that the rate a(x) determines
the time scale for homeostatic turnover or recovery from
lymphopaenia. Even if we conservatively use the slowest
estimates of memory turnover rates and we neglect the
increase in homeostatic proliferation observed under lym-
phopaenia, our basic conclusion is unchanged. We describe it
in the following section.
HIV and Memory CD4
þ T Cells—The ‘‘Slow Runaway’’
Hypothesis
We now propose a minimal model of the interaction
between HIV and memory CD4
þ homeostasis (Figure 2).
We assume that homeostatically activated or dividing cells
(y) are more susceptible to HIV infection than resting cells (x).
We also assume that infection of the homeostatically dividing
cells occurs at a rate proportional to both the average viral
infectivity p, a parameter that represents the efﬁciency of
infection, and the viral load, which we take to be proportional
to the number of infected cells at any time (z). Infected cells
have a short lifetime (v ’ 0.5 d
 1 [41]). For now we assume
resting cells cannot be infected, but this assumption can be
relaxed without affecting our conclusions.
We consider the dynamics of the T cell pool from the
beginning of the chronic phase of infection. Our model
predicts that total memory CD4
þ T cell numbers (x þ y þ z)
decline to a set-point which is inversely related to p (Figure 3)
and increases with v. Moreover, the approach to this set point
is rapid, on a time scale of weeks to months, a time scale
determined given by the average time between homeostatic
divisions, 1/a (Figure 4). In other words, homeostatic
activation-driven infection alone cannot explain the observed
rate of memory CD4
þ decline in HIV infection. Adding other
factors such as infection of resting cells increases the rate of
approach to the steady state. We note that even the slowest
published estimates of CD4
þmemory T cell turnover rates are
too rapid to explain the slow progression of HIV infection as
a transient decline to a state of low T cell numbers.
The Effect of Immune Activation
This model does not include immune-activated cells, which
may be recruited from naive or memory CD4
þ populations.
Figure 2. Extending the Previous Model of Memory CD4
þ Homeostasis
to Include HIV Infection
We now assume that activated cells are infected at a rate proportional to
the virus load (which in turn is assumed to be proportional to the
productively infected cell count z) and an infectivity parameter p that
models the efficiency of the infection process.
dx
dt
¼ 2ry   aðxÞx   dðxÞx
dy
dt
¼ aðxÞx  ð r þ lÞy   pzy
dz
dt
¼ pzy   vz
doi:10.1371/journal.pmed.0040177.g002
Figure 3. Steady-State Pool Size as a Function of Virus Infectivity p
We choose units of peripheral blood cell counts such that healthy
memory CD4
þ T cell numbers are unity. Below a threshold value of p the
infection fails to take hold. We expect HIV infections to correspond to the
area right of this threshold.
doi:10.1371/journal.pmed.0040177.g003
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þ T Cell Depletion in HIV InfectionImmune-activated (which we deﬁne as either antigen- or
bystander-activated) cells make the dominant contribution to
increased T cell turnover during HIV infection, which
decreases rapidly and substantially when viral replication
and new infection is blocked by ART [19]. This reduction in
IA and turnover presumably leaves homeostatic compensa-
tion as the dominant source of elevated turnover during
treatment.
Chronic T cell activation comprises several processes—
recruitment from naive or resting memory CD4
þ compart-
ments, rapid proliferation, and death, either through
activation-induced cell death or by cytopathic infection.
Immune-activated cells may also return to a resting memory
state. In other words, we argue that the chronic IA picture is
essentially of a form similar to Figure 2, with the addition of
more extensive division and death of activated (effector-
phenotype) cells. To explore its effect on the dynamics of the
T cell pool as a whole, we extended the model to include IA as
well as homeostatic proliferation (Figure 5).
The average rate of antigen or bystander activation (a*) per
memory CD4
þT cell in untreated HIV infection is not known.
The death rate c1 has been estimated for acute LCMV
infections [37] and is of the order 0.2 d
 1 for antigen-speciﬁc
CD4
þ T cells. This estimate may be reduced under conditions
of chronic stimulation as in HIV infection. We choose the
rate of return to resting memory c2 to be 10% of the effector
cell death rate. However, our results are insensitive to the
choice of c1 and c2.
When a* is comparable to or larger than the rate of
homeostatic proliferation a, the approach to a dynamic
equilibrium is even more rapid than in the simpler model
(and the set point is lower for a given set of parameters p and
v) as might be expected intuitively (simulation results not
shown). In Figures 6 and 7 we illustrate the predictions of the
model when the average rate of IA, a*, is smaller than the
homeostatic activation rate a. In this case we see that the
approach to a steady state is still too rapid to explain the
progression of chronic HIV infection. The key point here is
that in the presence of low average rates of IA, homeostatic
activation provides a lower bound on the average time
between T cell activation events and so determines the time
scale of equilibration of the memory CD4
þ T cell compart-
ment. Thus other mechanisms must be invoked to explain the
slow failure of homeostasis in HIV infection.
Latent Infection
Resting cells may be infected—potentially with lower
susceptibility—and generate virus upon activation. Including
latent infection and assuming that these cells behave as
normal resting memory cells, our conclusions are unchanged.
Latently infected cells may be required to account for viral
‘‘rebound’’ after cessation of ART (see Discussion).
Thymic Output and Naive Cells
The results we describe above are robust to adding small
inﬂux terms into either resting or activated memory CD4
þ
compartments from the naive population. Naive CD4
þ T cells
show very little homeostatic turnover under normal condi-
tions and are likely to be replenished largely by thymic output,
which may be signiﬁcantly impaired in HIV infection [42].
Figure 4. The Predicted Time for Memory CD4
þ T Cell Numbers to
Decline from 100% to 50% of Healthy Numbers, as a Function of Virus
Infectivity p
Parameter values (see model equations in caption to Figure 2): a(x)¼a0(1
  x/j), where a0 ¼ 1/30 d
 1, giving a(x*) ’ 1/60 (here x* refers to the
steady state numbers of resting memory CD4
þ T cells in an uninfected
individual); j¼1; d(x)¼d0 x/j, where d0¼1/200, giving d(x*) ’ 1/400; l
¼ 1.06; v ¼ 0.5; and r ¼ 1 (all rates in units of d
 1).
doi:10.1371/journal.pmed.0040177.g004
Figure 5. Extending the Model of Memory CD4
þ T Cell Dynamics in HIV
Infection to Include Both Homeostatically Activated (y) and Antigen- or
Bystander-Activated Cells (w)
Resting memory cells can undergo homeostatic proliferation at rate a, as
before; they can also be antigen- or bystander-activated at rate a* and
undergo a fold expansion f in the process. These cells are infected at rate
pz, die at rate c1, or return to a resting memory state at rate c2. The
results we present here are insensitive to the values of c1, c2, and f,
which we take to be 0.2 d
 1, 0.02 d
 1, and 100, respectively.
dx
dt
¼ 2ry  ð aðxÞþa Þx   dðxÞx þ c2w
dy
dt
¼ aðxÞx  ð r þ lÞy   pzy
dw
dt
¼ fa x  ð c1 þ c2Þy   pzw
dz
dt
¼ pzðy þ wÞ vz
doi:10.1371/journal.pmed.0040177.g005
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þ T Cell Depletion in HIV InfectionFurther, under lymphopaenic conditions, naive T cells may
proliferate and acquire an activated or memory-type pheno-
type [43]. The role of thymic output as a factor controlling the
rate of disease progression has been discussed previously [44].
However, in our model the rapid rate of approach to an
equilibriummemory pool size is not signiﬁcantly perturbed by
small rates of inﬂux from other compartments.
Model Predictions
The predicted dependence of steady state pool size with p
allows comparisons to be drawn with other measurements of
virusinfectivityintheliterature.Inourmodelthekeyquantity
is the rate of infection per activated CD4
þT cell, or pz, where z
is the number or density of productively infected cells. In
models used extensively elsewhere in the HIV literature (see,
for example, [45]), the corresponding quantity is usually
denoted kV, where V is the concentration of virus in plasma
and k is a ‘‘force of infection.’’ Mu ¨ller et al. [46] estimate kV to
be in the range 0.01–0.5 d
 1 from in vivo data (actually the
quantity f^ bV in their notation). Dixit and Perelson [47]
estimate rates of infection in vitro and quote comparable
values of kV ’ 0.02   1d
 1, although these estimates should
probably be increased for populations of activated target cells.
Our model predicts the equivalent quantity (pz) to be in the
range 0–0.2 d
 1 for 100 , p , 1,000 and for all levels of IA.
Steady state numbers of cells at around 50% of healthy
numbers correspond to values of pz of approximately 0.1 d
 1,
in reasonable agreement with these studies.
Qualitatively, we note that our model predicts that even
after inhibition of viral replication with ART (that is,
reduction of p), average death rates will remain higher than
healthy levels during the return to a higher homeostatic set
point. This prediction of elevated cell death even during the
recovery of cell numbers arises because in our model
proliferating cells are more susceptible to death than are
resting cells, as has been noted previously in other HIV
modelling studies [48,49].
Discussion
We have used a simple and robust model to reject a
mechanism for CD4
þ T cell decline in chronic HIV infection.
However, the model has two key limitations. First, while it
distinguishes between quiescent and proliferating memory
CD4
þT cells, it neglects other potential sources of phenotypic
heterogeneity within this population with respect to activa-
tion, proliferation, and death. Second, it assumes that cells’
replicative capacity remains intact after repeated rounds of
stimulation. Chronically stimulated cells may become sen-
escent and progressively lose their ability to proliferate or
survive. With these caveats in mind, we can still use the model
to frame alternative hypotheses for the mechanism driving
the set point in the chronic phase of infection slowly towards
an AIDS state. Many hypotheses have been discussed in the
literature, all of which involve proposing an additional slow
process in T cell population dynamics. We summarise them
below in the context of T cell homeostasis.
Exhaustion of CD4
þ subpopulations. Chronic stimulation
may drive the accumulation of a heterogeneous population of
T cells exhibiting a nonresponsive or exhausted phenotype,
with higher susceptibility to apoptosis and reduced prolifer-
ative capacity [50]. This phenomenon is observed among
responding T cells in other persistent viral infections, but
may also occur among nonspeciﬁc (bystander-activated)
CD4
þ T cell populations in HIV infection. In Text S1 we
show how an extension to the model of a low constant rate of
differentiation of stimulated cells into an exhausted state can
generate a slow decline in total T cell numbers.
Virus evolution. Increasing the efﬁciency of infection, p,
lowers the memory CD4
þ set point in our model (Figures 3
and 6), suggesting a mechanism of decline in which
progression is driven by slow adaptation of the virus, as has
been proposed previously [51]. The infectivity p is a
compound parameter representing at least two distinct
quantities: (i) the probability of productive infection upon
encounter between a virion and a susceptible T cell, and (ii)
the dependence of plasma virion density on infected cell
numbers. The ﬁrst may change over the course of an infection
through a switch in coreceptor usage [52,53] or perhaps
changes in receptor expression of chronically stimulated
populations. The second may be inﬂuenced by virus
Figure 6. The Predicted Steady-State Pool Size as a Function of Virus
Infectivity p, in the Presence of Different Levels of Immune Activation a*
doi:10.1371/journal.pmed.0040177.g006
Figure 7. The Predicted Time Course of CD4
þMemory T Cell Numbers as
They Decline to Their Steady State Level for Different Levels of Immune
Activation a* in the Presence of HIV
Steady state levels are indicated by dashed lines. The infectivity
parameter p ¼ 200; other parameters are as in previous figures.
doi:10.1371/journal.pmed.0040177.g007
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per infected cell) or the rate of clearance of free virions by
antibodies, which may fall as new mutants emerge and/or the
availability of T cell help wanes. These processes could be
distinguished by assessing whether virus in patients in the
chronic phase of infection shows an increasing capacity to
infect host CD4
þ T cells ex vivo over time. We note that this
measure of ﬁtness is not necessarily related to virus diversity.
Clinical evidence is conﬂicting in this regard, and the
association between diversity and progression is unclear
[54–56]. A further possibility is that within-host virus
evolution causes a progressive increase in the per capita rate
of immune or bystander activation. As can be seen in Figure
7, our model predicts that increasing this rate will lower the
steady-state number of memory CD4
þ T cells.
Failure of immune surveillance. Impaired T cell help and/
or CTL exhaustion may decrease the rate of recognition and
killing of infected cells by CTLs (contained in the rate
constant v in the model above) over time [57]. Thus despite
the low frequency of infected cells, changes in the efﬁciency
with which they are removed can produce an impact on the T
cell compartment as a whole. CTL killing can now be
quantiﬁed directly in vivo [58] and longitudinal measure-
ments of killing rates may help us to assess whether declining
CTL function drives progression. However, this potential
mechanism shifts the problem to explaining the slow rate of
CTL exhaustion in HIV infection, which is faster in other
chronic infections [59].
Attrition of homeostatic resources. Homeostasis may be
impaired in HIV infection due to damage to lymphoid
architecture [3,60]. Thus chronic inﬂammation may progres-
sively lower the homeostatic set point by diminishing the
availability of T cell proliferation or survival signals. Our
model predicts that in the absence of HIV infection, CD4
þ
memory numbers increase with the activation rate a—
however, they fall with increasing a and a* in the presence
of HIV, as activation renders more cells susceptible to
infection and destruction. This prediction implies that if
destruction of lymphatic infrastructure is the source of
memory CD4
þ T cell decline in HIV, its dominant effect on T
cell dynamics must be to increase the death rate of activated
cells l. The dynamics of activated cells strongly dictate the
dynamics of the pool as a whole; the model predicts that
increases in the average death rate of activated cells l by as
little as a factor of two above healthy levels can lead rapidly to
profound depletion in the steady state memory T cell
numbers.
Mutational meltdown or senescence. In this model, in-
creased turnover of T cells results in the accumulation of
deleterious mutations and impairs their regenerative or
survival capacity [61]. The rate at which these mutations
accumulate could then determine the time scale of decline.
Phenotypic changes induced by repetitive stimulation (e.g., an
approach to a terminally differentiated state) may provide a
similar mechanism of impairing the average regenerative
capacity of the population as a whole. Following a similar
argument to that above, a decline in memory CD4
þ numbers
is most likely to be driven by an increase in death rates among
persistently stimulated, senescent cells, rather than a decrease
in their proliferation rate.
Immune hyperactivation. As we have shown, IA in the
presence of HIV can cause a reduction in the set point
memory CD4
þcell numbers, but the set point for a given level
of IA is attained too rapidly to explain the slow depletion of
these cells. However, our model predicts that a slow,
progressive increase in the per capita rate of activation could
cause a downward drift of the set point. Alternatively, and
perhaps more plausibly, the immune hyperactivation and
heightened homeostatic proliferation may drive a slow
increase in the average death rate in the memory population
through senescence or exhaustion, as described above [50,61].
Summary
All of these models seek to explain the imbalance between
the average rates of division and death across the CD4
þ
memory pool, and are therefore all variants of the ‘‘tap and
drain’’ hypothesis. Distinguishing between them is obviously
important for treatment of infection, and while none are
mutually exclusive each may contribute to different extents
in infected individuals. Additional information, however,
comes from the phenomenon of viral rebound—after
cessation of ART, the rapid increase of viral load and decline
of CD4
þ counts in peripheral blood to approximately
pretreatment levels [62]. Assume that treatment drives the
infectivity parameter p from an initial value p0 to a value close
to zero, and markedly reduces levels of IA (a* in the models
above), which is likely to be an increasing function of the viral
load and/or p. If reservoirs of latently infected cells persist
during treatment, retaining a representative memory of the
pretreatment virus population, the virus adaptation model
predicts that allowing viral replication to restart will drive the
memory CD4
þnumbers quickly—on a time scale of weeks—to
the pretreatment set point determined by p0, a*, and the
remaining (constant) homeostatic parameters. Other models
predict the rapid return to the previous set point only if the
homeostatic parameters remain constant during treatment—
that is, if there is not signiﬁcant recovery of CTL function or
repair of lymphoid architecture or T cell regenerative
capacity while virus replication is suppressed.
Clearly the virus adaptation model is not the whole story.
Assuming treatment effectively abrogates the production of
virus, this model predicts the full reconstitution of the T cell
memory compartment during sustained treatment, which is
not usually observed. This discrepancy between the virus
adaptation model and the observations implies an additional
role for lasting impairment to homeostatic mechanisms in
HIV infection, perhaps from attrition of homeostatic
resources or through differentiation (senescence or exhaus-
tion).
In this paper we have used a model of self-renewing
memory CD4
þ T cell pool to reject the idea of slow runaway
decline in HIV infection, in which homeostatic compensation
and/or IA drives infection, higher viral loads, more recruit-
ment of cells into an activated state, and further infection
events—and intuitively should lead to erosion of the memory
CD4
þ compartment. We argue that this mechanism fails to
explain the slow decline of this cell population in the chronic
phase of HIV infection. The model indicates that the memory
CD4
þ T cell pool will reach a dynamic equilibrium or set
point within weeks or months of the end of the acute
infection, a time scale that is dictated by the average time
between homeostatic proliferation events. However, the
‘‘runaway’’ model may well be an appropriate description
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þ T Cell Depletion in HIV Infectionof depletion in the early stages of infection, and particularly
among responding HIV-speciﬁc cells. Our study highlights
how understanding memory CD4
þ T cell dynamics in chronic
HIV infection requires a quantitative description of T cell
homeostasis in health, as well as knowledge of how HIV
affects the turnover and differentiation of T cell subsets.
Methods
The ordinary differential equation models used in this
study were simulated and analysed using Mathematica [63].
Supporting Information
Text S1. A Model for CD4 Decline Driven by the Slow Accumulation
of Chronically Stimulated, Nonresponsive Cells
We illustrate with an extension to the model how adding hetero-
geneity to the memory CD4
þ T cell population, in the form of slow
differentiation into an exhausted or less responsive phenotype
induced by chronic exposure to HIV antigens or inﬂammatory
signals, can induce a slow decline in total cell numbers.
Found at doi:10.1371/journal.pmed.0040177.sd001 (303 KB PDF).
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Editors’ Summary
Background. The AIDS virus causes disease by inactivating the body’s
immune responses. Most severely affected are the white blood cells
known as T lymphocytes, particularly the CD4
þ T cells that recognize
infection and enable other cells of the immune system to respond
against it. Following rapid loss in the first few weeks of HIV infection, the
number of CD4
þ cells in the blood falls slowly, often over a period of ten
years or longer. The exact mechanisms by which CD4
þ cell depletion
occurs are not fully understood.
Why Was This Study Done? For over a decade, researchers have used a
‘‘tap and drain’’ analogy to describe CD4
þ cell loss. In this description,
CD4
þ cells (like water in a sink) are constantly being eliminated by HIV
(the drain), while the body is constantly replacing them with new ones
(the tap). Over time, the tap cannot keep up with the drain, and CD4
counts begin to drop, leaving the body susceptible to the infections that
define AIDS.
CD4þ cells that are activated in response to invading microbes (such
as HIV) are highly susceptible to infection with HIV, and following
infection these cells may produce many new copies of HIV before
dying. Therefore, one popular explanation for CD4
þ cell loss is the
‘‘runaway’’ hypothesis, in which CD4
þ cells infected by HIV produce
more virus particles, which activate more CD4
þ cells that in turn
become infected, leading to an ongoing cycle of CD4
þ cell activation,
infection, HIV production, and cell destruction. The authors wanted to
investigate whether this hypothesis can explain why CD4
þ cell levels
fall slowly.
What Did the Researchers Do and Find? Using a mathematical model
(a series of equations to describe the processes by which CD4
þ cells are
produced and eliminated), the authors show that, if the ‘‘runaway’’
hypothesis were correct, then CD4
þ cells would fall to low levels over a
few months, not over several years. They therefore conclude that the
‘‘runaway’’ hypothesis cannot explain the slow pace of CD4
þ cell
depletion in HIV infection.
What Do These Findings Mean? These results show that a slow process
must be active in the HIV-induced depletion of CD4
þ cells. Because of its
simplicity, the model used in this study is convincing in its rejection of
the runaway hypothesis, but a more detailed analysis will be needed to
tell us precisely what the slow process is. One possibility raised by the
authors is that this process is the slow adaptation of the virus itself over
the course of infection. Specifically identifying this process will provide a
key insight into the nature of HIV disease and indicate potential new
approaches to therapy.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040177.
  Read the related Perspective on this article by Rob J. de Boer
  University of California, San Francisco’s HIV InSite Knowledge Base
includes information on HIV immunology
  The National Institute of Allergy and Infectious Diseases provides AIDS
fact sheets and brochures that cover a variety of topics
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